On Demand CE - Heart Failure: A 2016 Update

Heart Failure: A 2016 Update

Learn what's new, what's changing and what's still important in heart failure management. You'll hear about new approved drugs, some potential new treatments for preserved injection fraction, and new data on traditional self-care strategies.

Credit: 1.0 Hour CE (1.0 Pharmacology)
Cost: Free

Take this Course


  • Sue Wingate, PhD, RN, ANP-BC

Upon completion of this program, participants will be able to: 

  • List two new drug classes approved in 2015 for the treatment of heart failure
  • List two specific goals for patient education regarding risk and benefit for these new therapies.
  • Identify the indications for the use of ivabradine
  • Identify the indications for the use of the combination agent sacubitril/valsartan in the patient with heart failure

Sue Wingate, A Heart Failure Update
This educational activity is provided by the Preventive Cardiovascular Nurses Association (PCNA). PCNA is approved as a provider of nurse practitioner continuing education (CE) programs by the American Association of Nurse Practitioners (AANP), provider number 030602.